NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Krispy Kreme, Inc. (NASDAQ: DNUT). Shareholders who purchased shares of DNUT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/krispy-kreme-inc-loss-submission-form/?id=155077&from=3 CLASS PERIOD: March 26, ...

NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Vestis Corporation (NYSE: VSTS). Shareholders who purchased shares of VSTS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/vestis-corporation-loss-submission-form/?id=155076&from=3 CLASS PERIOD: May 2, 20 ...

NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Organon & Co. (NYSE: OGN). Shareholders who purchased shares of OGN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/organon-co-loss-submission-form/?id=155074&from=3 CLASS PERIOD: October 31, 2024 to Apri ...

NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Petco Health and Wellness Company, Inc. (“Petco” or “the Company”) (NASDAQ: WOOF) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise ...

NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of 3D Systems Corporation (NYSE: DDD). Shareholders who purchased shares of DDD during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/3d-systems-corporation-loss-submission-form/?id=155073&from=3 CLASS PERIOD: Aug ...

NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of DoubleVerify Holdings, Inc. (NYSE: DV). Shareholders who purchased shares of DV during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/doubleverify-holdings-inc-loss-submission-form-2/?id=155071&from=3 CLASS PER ...

关于出版商Proactive - 公司提供快速、可访问、信息丰富且可操作的商业和金融新闻内容，面向全球投资受众[2] - 内容由经验丰富的新闻记者团队独立制作，团队分布在伦敦、纽约、多伦多、温哥华、悉尼和珀斯等全球主要金融和投资中心[2] - 专注于中小市值市场，同时覆盖蓝筹股公司、大宗商品和更广泛的投资故事[3] 行业覆盖领域 - 团队提供跨市场的新闻和独特见解，包括但不限于生物技术和制药、采矿和自然资源、电池金属、石油和天然气、加密货币以及新兴数字和电动汽车技术[3] 技术应用 - 公司采用前瞻性技术，内容创作者拥有数十年的宝贵专业知识和经验[4] - 团队使用技术辅助和增强工作流程，偶尔会使用自动化和软件工具，包括生成式AI[4][5] - 所有发布的内容均由人类编辑和撰写，符合内容生产和搜索引擎优化的最佳实践[5]

NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders who purchased shares of WST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/west-pharmaceutical-services-inc-loss-submission-form/?id=155069&fr ...

公司诉讼事件 - Sarepta Therapeutics公司面临集体诉讼 指控其在2023年6月22日至2025年6月24日期间发布重大虚假或误导性声明 [3] - 诉讼涉及基因疗法ELEVIDYS的安全性问题 包括未披露患者重大安全风险及试验方案缺陷 [3] - 公司被指隐瞒ELEVIDYS严重不良反应 导致试验招募暂停并引发监管审查风险 [3] 法律程序进展 - 股东参与集体诉讼的截止日期为2025年8月25日 需通过指定链接登记 [4] - 登记股东将获得案件生命周期内的状态更新 无需承担参与成本 [4] - 牵头原告申请截止日期同为2025年8月25日 但非强制参与条件 [1][4] 涉事产品影响 - ELEVIDYS作为治疗杜氏肌营养不良的基因疗法 其现有及扩展批准风险因安全性问题加剧 [3] - 不良反应严重程度直接影响公司临床试验进程 包括暂停给药等操作 [3]

公司诉讼事件 - Fortrea Holdings Inc (NASDAQ: FTRE) 面临集体诉讼 涉及2023年7月3日至2025年2月28日期间购买股票的股东 [3] - 诉讼指控公司在上述期间发布 materially false and/or misleading statements [3] - 公司被指控高估长期项目(Pre-Spin Projects)对2025年收益的贡献 [3] - 公司被指控夸大退出过渡服务协议可能实现的成本节约 [3] - 公司2025年EBITDA目标被指夸大 [3] - 公司分拆后商业模式及业务/财务前景的可行性被指高估 [3] 诉讼时间节点 - 股东需在2025年8月1日前登记参与集体诉讼 [4] - 股东登记后将获得案件进展监控服务 [4] - 申请成为首席原告的截止日期为2025年8月1日 [4] 律师事务所信息 - The Gross Law Firm 负责此集体诉讼案件 [5] - 该律所专注于保护因欺骗、欺诈和非法商业行为受损的投资者权益 [5] - 律所致力于确保企业遵守负责任的商业实践和良好企业公民行为 [5]